China NMPA Product Recall - Embolization devices, guidewires, floating microcatheters

Covidien Medical Devices International Trading (Shanghai) Co., Ltd., the Chinese responsible unit for Medtronic, announced a voluntary Class I recall for specific embolization devices, guidewires, and floating microcatheters. This high-priority recall, initiated in October 2016 and published by the National Medical Products Administration (NMPA) in December 2016, addresses a significant safety concern. The core issue is the potential delamination and peeling of the polytetrafluoroethylene (PTFE) coating on affected products, manufactured between July 2014 and September 2016. This defect could result in PTFE microparticles detaching and entering a patient's bloodstream, posing a risk of serious adverse events. Potential patient injuries include, but are not limited to, intracranial edema, systemic inflammatory responses, ischemic stroke, organ dysfunction, and shock. Operating under the NMPA's regulatory guidance for medical device recalls, the company implemented a global corrective action. Distributors of the affected products were notified via customer letter to meticulously check their existing inventory. All identified units corresponding to the specified models and batch numbers were to be returned to Medtronic for proper disposal. Importantly, for products already implanted or used in patients, no immediate medical intervention or action was mandated, with patient care continuing under standard medical protocols. This recall underscores a commitment to product safety and compliance within the medical device industry.